Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.
Private equity firm TPG Capital is homing in on a deal to acquire medicine and healthcare products company iNova Pharmaceuticals.PEP and Carlyle bought iNova in 2017 from US giant Valeant Pharmaceuticals.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sources said TPG had emerged from the auction as the most likely buyer after owners Pacific Equity Partners and The Carlyle Group took binding bids on Friday.
The business is expected to be worth more than $2 billion.TPG Capital was one of three known bidders – the others were its global PE rivals Blackstone and Bain Capital.
Sources said the talks to sign a deal were well advanced on Tuesday morning.
Source: Headtopics
Can’t stop reading? Read more
Sixth Street-backed Caris Life Sciences targets $5.35bn valuation in US IPO
Sixth Street-backed Caris Life Sciences targets $5.35bn valuation in US IPO Sixth Street-backed...
Advent eyes $5.06bn Spectris takeover in UK’s biggest buyout bid of 2025
Advent eyes $5.06bn Spectris takeover in UK’s biggest buyout bid of 2025 Advent International has...
CalPERS posts 11.3% private equity return as $92bn strategy revamp gains traction
CalPERS posts 11.3% private equity return as $92bn strategy revamp gains traction The California...